A recent discovery could change how we administer vaccines. Researchers have observed that the choice of arm for injections ...

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

The vaccine's prospects were thrown into doubt after the U.S. Food and Drug Administration missed its April 1 target to ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...

The advisory panel to the Centers for Disease Control and Prevention had made recommendations regarding the use of separate ...

Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after ...